Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression".
Saved in:
| Title: | Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression". |
|---|---|
| Authors: | Kamphuis JBJ; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France., Worrall WPM; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France., Stackowicz J; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France.; Sorbonne Université, 75006 Paris, France., Mougel A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France., Mauré E; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France., Conde E; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France.; Sorbonne Université, 75006 Paris, France., Bruhns P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France., Guilleminault L; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.; Department of Respiratory Medicine, Toulouse University Hospital, Faculty of Medicine, 31059 Toulouse, France., Gaudenzio N; Unité de Différenciation Epithéliale et Autoimmunité Rhumatoïde (UDEAR), UMR 1056, INSERM, Université de Toulouse, 31059 Toulouse, France., Chen J; Singapore Immunology Network, Agency for Science, Technology and Research, 138648 Singapore., Gentek R; Centre for Inflammation Research, University of Edinburgh, EH16 4TJ Edinburgh, UK., Reber LL; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France. laurent.reber@inserm.fr.; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France. |
| Source: | Science (New York, N.Y.) [Science] 2021 Apr 09; Vol. 372 (6538). |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33833094 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression". – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kamphuis+JBJ%22">Kamphuis JBJ</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Worrall+WPM%22">Worrall WPM</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Stackowicz+J%22">Stackowicz J</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France.; Sorbonne Université, 75006 Paris, France.<br /><searchLink fieldCode="AU" term="%22Mougel+A%22">Mougel A</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Mauré+E%22">Mauré E</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Conde+E%22">Conde E</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France.; Sorbonne Université, 75006 Paris, France.<br /><searchLink fieldCode="AU" term="%22Bruhns+P%22">Bruhns P</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France.<br /><searchLink fieldCode="AU" term="%22Guilleminault+L%22">Guilleminault L</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.; Department of Respiratory Medicine, Toulouse University Hospital, Faculty of Medicine, 31059 Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Gaudenzio+N%22">Gaudenzio N</searchLink>; Unité de Différenciation Epithéliale et Autoimmunité Rhumatoïde (UDEAR), UMR 1056, INSERM, Université de Toulouse, 31059 Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Singapore Immunology Network, Agency for Science, Technology and Research, 138648 Singapore.<br /><searchLink fieldCode="AU" term="%22Gentek+R%22">Gentek R</searchLink>; Centre for Inflammation Research, University of Edinburgh, EH16 4TJ Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Reber+LL%22">Reber LL</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France. laurent.reber@inserm.fr.; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220404511%22">Science (New York, N.Y.)</searchLink> [Science] 2021 Apr 09; Vol. 372 (6538). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0404511 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1095-9203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200368075%22">00368075 </searchLink><i>NLM ISO Abbreviation: </i>Science <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33833094 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1126/science.abf2022 Languages: – Code: eng Text: English Titles: – TitleFull: Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression". Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kamphuis JBJ – PersonEntity: Name: NameFull: Worrall WPM – PersonEntity: Name: NameFull: Stackowicz J – PersonEntity: Name: NameFull: Mougel A – PersonEntity: Name: NameFull: Mauré E – PersonEntity: Name: NameFull: Conde E – PersonEntity: Name: NameFull: Bruhns P – PersonEntity: Name: NameFull: Guilleminault L – PersonEntity: Name: NameFull: Gaudenzio N – PersonEntity: Name: NameFull: Chen J – PersonEntity: Name: NameFull: Gentek R – PersonEntity: Name: NameFull: Reber LL IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 04 Text: 2021 Apr 09 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1095-9203 Numbering: – Type: volume Value: 372 – Type: issue Value: 6538 Titles: – TitleFull: Science (New York, N.Y.) Type: main |
| ResultId | 1 |
